Info
- Utilizzare la checkbox di selezione a fianco di ciascun documento per attivare le funzionalità di stampa, invio email, download nei formati disponibili del (i) record.
Parkinson's disease management through ICT : the REMPARK approach / / Joan Cabestany, Àngels Bayés, editors
| Parkinson's disease management through ICT : the REMPARK approach / / Joan Cabestany, Àngels Bayés, editors |
| Pubbl/distr/stampa | Gistrup, Denmark ; ; Delft, the Netherlands : , : River Publishers, , 2017 |
| Descrizione fisica | 1 online resource (250 pages) : illustrations, tables |
| Disciplina | 616.83306 |
| Collana | River Publishers Series in Biomedical Engineering |
| Soggetto topico |
Parkinson's disease - Treatment
Parkinson's disease - Diagnosis |
| Soggetto genere / forma | Electronic books. |
| ISBN | 87-93519-45-1 |
| Formato | Materiale a stampa  |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Record Nr. | UNINA-9910467840803321 |
| Gistrup, Denmark ; ; Delft, the Netherlands : , : River Publishers, , 2017 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Parkinson's disease management through ICT : the REMPARK approach / / Joan Cabestany, Angels Bayes, editors
| Parkinson's disease management through ICT : the REMPARK approach / / Joan Cabestany, Angels Bayes, editors |
| Edizione | [First edition.] |
| Pubbl/distr/stampa | Gistrup, Denmark ; ; Delft, the Netherlands : , : River Publishers, , 2017 |
| Descrizione fisica | 1 online resource (250 pages) : illustrations, tables |
| Disciplina | 616.83306 |
| Collana | River Publishers series in biomedical engineering |
| Soggetto topico |
Parkinson's disease - Treatment
Parkinson's disease - Diagnosis |
| ISBN |
1-00-333903-4
1-000-79688-4 1-003-33903-4 1-000-79372-9 87-93519-45-1 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
Front Cover -- Half Title Page -- RIVER PUBLISHERS SERIES IN BIOMEDICAL ENGINEERING -- Title Page - Parkinson's Disease Management through ICT: The REMPARK Approach -- Copyright Page -- Contents -- Preface -- List of Contributors -- List of Figures -- List of Tables -- List of Abbreviations -- Chapter 1 - Parkinson's Disease Management: Trends and Challenges -- 1.1 Introduction -- 1.2 Impact and Strategies of PD at Different Stages -- 1.2.1 Patients in Early Stages -- 1.2.2 Moderately Affected Patients -- 1.2.3 Severely Affected Patients -- 1.3 QoL in PD -- 1.4 State of Art of Current Trends in PD Management -- 1.5 Needs and Challenges for Optimal PD Management -- 1.6 Conclusion -- References -- Chapter 2 - Objective Measurement of Symptoms in PD -- 2.1 Advancing Parkinson's Disease: Motor and Non-Motor Fluctuations -- 2.1.1 Motor Fluctuations -- 2.1.2 Non-Motor Fluctuations -- 2.2 Challenges in Documenting "Real-World" Fluctuating PD Symptoms -- 2.3 Emerging Technologies to Monitor Symptom Fluctuations -- 2.4 Challenges in the Use of Inertial Sensor Technology in Monitoring PD Symptoms -- 2.5 Conclusion -- References -- Chapter 3 - The REMPARK System -- 3.1 Introduction -- 3.2 REMPARK System Overview -- 3.2.1 The Immediate Level -- 3.2.2 The Mid-Term Level -- 3.3 Definition of the REMPARK System Main Characteristics -- 3.4 Subsystems Specification -- 3.4.1 Sensor Module -- 3.4.2 Auditory Cueing Subsystem -- 3.4.2.1 Gait guidance ACS functional description -- 3.4.2.2 Need of an adaptive ACS -- 3.4.3 Drug Delivery Pump Considerations -- 3.4.4 The smartphone Technical Requirements -- 3.4.5 The REMPARK Platform Architecture and Functionality -- 3.4.5.1 Important functional parts -- 3.4.5.1.1 Rule Engine -- 3.4.5.1.2 Disease Management System -- 3.4.5.2 Platform technical constraints -- 3.5 Conclusion -- References.
Chapter 4 - Assessment of Motor Symptoms -- 4.1 Introduction -- 4.2 Decision on the Most Relevant Symptoms to Be Detected and Assessed -- 4.2.1 Subjects -- 4.2.2 Questionnaire -- 4.2.3 Results -- 4.2.3.1 Analysis of the correlation between responses on clinical questions -- 4.2.3.2 Investigation of the clinical relevance of the motor symptoms in the three PD phases (i.e., mild, moderate and advanced) -- 4.2.3.3 Analysis of REMPARK utility for PD patients -- 4.2.4 Discussion and Conclusive Remarks -- 4.3 Methodology and Database to Monitor Motor Symptoms -- 4.3.1 An Artificial Intelligence Approach and the Need of Relevant Data -- 4.3.2 Protocol for the Database Construction -- 4.3.3 Gathered Database Description -- 4.4 Algorithmic Approach and Results -- 4.4.1 Dyskinesia Detection Algorithm -- 4.4.2 Bradykinesia Detection Algorithm -- 4.4.3 Tremor Detection Algorithm -- 4.4.4 Freezing of Gait (FOG) Detection Algorithm -- 4.4.5 Gait Parameters Estimation -- 4.4.6 Fall Detection Algorithm -- 4.4.7 ON/OFF Motor State Estimation -- 4.5 Conclusions -- References -- Chapter 5 - Sensor Sub-System -- 5.1 Introduction -- 5.2 Sensor's Data Processing Flow -- 5.3 Hardware Requirements -- 5.3.1 Memory Requirements -- 5.3.2 Sampling Frequency and Full-Scale Values -- 5.3.3 Time Restrictions on the On-Line Implementation -- 5.4 Sensor Device Components -- 5.4.1 Microcontroller -- 5.4.2 Accelerometer Details -- 5.4.3 Bluetooth Module -- 5.4.4 Power Management -- 5.4.5 External Memory Unit -- 5.5 Sensor Casing and Operation -- 5.6 Conclusion -- References -- Chapter 6 - User Interaction -- 6.1 Introduction -- 6.2 State of the Art/Competitive Analysis -- 6.3 Interaction Guidelines for Users with Parkinson's Disease -- 6.4 User Research and User-Centred Design Processes -- 6.5 Final Usability Tests -- 6.5.1 Research Questions -- 6.5.2 Sample. 6.5.3 Protocol, Script and Metrics -- 6.5.4 Results -- 6.5.4.1 Appointment test -- 6.5.4.2 Medication test -- 6.6 Conclusions after the User-Centred Process -- 6.7 Characteristics of REMPARK Smartphone Applications -- 6.8 Some Concluding Remarks -- References -- Chapter 7 - Actuator Sub-System: The Auditory Cueing -- 7.1 Introduction -- 7.2 Cueing Strategies for Gait in Parkinson's Disease -- 7.3 State of the Art: Competitive Analysis -- 7.4 REMPARK Auditory Cueing System (ACS) -- 7.5 Outcomes from Field Trials: Future Considerations -- 7.6 A Step Further in REMPARK: Automatic Drug Administration -- 7.7 Conclusion -- References -- Chapter 8 - Disease Management System (DMS) -- 8.1 Introduction -- 8.2 Disease Management System Application -- 8.3 DMS Functional Organization -- 8.4 Advantages Using the Disease Management System (DMS) -- 8.4.1 Advantages for the Clinical Team -- 8.4.2 Advantages for the Patients -- 8.4.3 Advantages for the Organization -- 8.5 Conclusions, Discussion and Vision -- References -- Chapter 9 - REMPARK System Assessment: Main Results -- 9.1 Introduction -- 9.2 Description of Main Communication Flows -- 9.2.1 Type of Transmitted Information -- 9.2.2 Security Aspects -- 9.2.3 Final Deployment and Implementation of the REMPARK Platform -- 9.3 Pilot for the REMPARK System Assessment: Description -- 9.3.1 Definition of the Pilots' Objectives and Eligibility Criteria -- 9.3.2 Design of the Study -- 9.3.3 Pre-Pilot Conclusions -- 9.4 REMPARK Pilots' Execution and Obtained Results -- 9.4.1 Performance of the System -- 9.4.2 Validity of the ON-OFF Detection Algorithm -- 9.4.2.1 The methodology -- 9.4.2.2 Validation of the ON-OFF diaries: available data -- 9.4.2.3 Results of the ON/OFF state detection -- 9.4.3 Non-Motor Symptoms Descriptive Analysis -- 9.4.4 Efficacy and Effectiveness of the Cueing System. 9.5 Health-Safety of the REMPARK System -- 9.6 Usability and User Satisfaction of the REMPARK System -- 9.7 Summary and Conclusions -- References -- Chapter 10 - Epilogue and Some Conclusions -- 10.1 Summary of PD Symptoms and the Influence on QoL -- 10.2 Existing Barriers of PD Management -- 10.3 The Role of the REMPARK System in the Context -- 10.4 Limitations of the REMPARK System -- 10.5 Clinical Applicability of the REMPARK System -- 10.6 As a Concluding Remark -- References -- Index -- About the Editors. |
| Record Nr. | UNINA-9910632997203321 |
| Gistrup, Denmark ; ; Delft, the Netherlands : , : River Publishers, , 2017 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||